Theragnostic Technologies Inc - Product Pipeline Analysis, 2019 Update



Theragnostic Technologies Inc (Theragnostic Technologies) is a biomedical company that focuses on research and development of novel nanoparticle-based carrier platforms for diagnostic, therapeutic and regenerative medicine. The company develops multi-functional graphene-based carrier platform that harnesses the physical (magnetic, electromagnetic and acoustic) and chemical properties of graphene to generate a diversified product pipeline such as diagnostic agents, monitoring agents, therapeutic agents, and regenerative agents. It offers MRI contrast agent, delivery system, and implantable nano-materials. The company also has robust product pipeline with multiple research, preclinical and preclinical IND (investigational new drug) candidates in development. Theragnostic Technologies is headquartered in New York City, New York, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Theragnostic Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
 


Theragnostic Technologies Inc Company Overview
Theragnostic Technologies Inc Company Snapshot
Theragnostic Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
Theragnostic Technologies Inc – Pipeline Analysis Overview
Theragnostic Technologies Inc - Key Facts
Theragnostic Technologies Inc - Major Products and Services
Theragnostic Technologies Inc Pipeline Products by Development Stage
Theragnostic Technologies Inc Pipeline Products Overview
GraFix - Burn Wounds
GraFix - Burn Wounds Product Overview
GraFix - Open Fractures
GraFix - Open Fractures Product Overview
Mangradex
Mangradex Product Overview
ManGraDex - IV Renal Imaging
ManGraDex - IV Renal Imaging Product Overview
Mangradex - Molecular Breast Cancer Screening
Mangradex - Molecular Breast Cancer Screening Product Overview
Mangradex - MRI Sentinel Lymph Node
Mangradex - MRI Sentinel Lymph Node Product Overview
Theragnostic Technologies Inc - Key Competitors
Theragnostic Technologies Inc - Key Employees
Theragnostic Technologies Inc - Locations And Subsidiaries
Head Office
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
 


List Of Tables


Theragnostic Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
Theragnostic Technologies Inc Pipeline Products by Equipment Type
Theragnostic Technologies Inc Pipeline Products by Indication
Theragnostic Technologies Inc, Key Facts
Theragnostic Technologies Inc, Major Products and Services
Theragnostic Technologies Inc Number of Pipeline Products by Development Stage
Theragnostic Technologies Inc Pipeline Products Summary by Development Stage
GraFix - Burn Wounds - Product Status
GraFix - Burn Wounds - Product Description
GraFix - Open Fractures - Product Status
GraFix - Open Fractures - Product Description
Mangradex - Product Status
Mangradex - Product Description
ManGraDex - IV Renal Imaging - Product Status
ManGraDex - IV Renal Imaging - Product Description
Mangradex - Molecular Breast Cancer Screening - Product Status
Mangradex - Molecular Breast Cancer Screening - Product Description
Mangradex - MRI Sentinel Lymph Node - Product Status
Mangradex - MRI Sentinel Lymph Node - Product Description
Theragnostic Technologies Inc, Key Employees
Glossary
 


List Of Figures


Theragnostic Technologies Inc Pipeline Products by Equipment Type
Theragnostic Technologies Inc Pipeline Products by Development Stage
 


Mind Technologies Inc (MIND) - Financial and Strategic SWOT Analysis Review

MIND Technologies Inc (MIND) is a diversified company. The company designs, manufactures and markets marine sonar and seismic equipment, exploration equipment and specialized equipment. It offers seismic source acquisition and

USD 300 View Report

Theralink Technologies Inc (OBMP) - Financial and Strategic SWOT Analysis Review

Theralink Technologies Inc (Theralink), formerly OncBioMune Pharmaceuticals Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The companys products comprise biosimilars and vaccines developed for cancer types such

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available